Literature DB >> 15151852

Electromyographic evidence of neurological controller signals with viscous load.

B Hannaford1, V Lakshminarayanan, L Stark, M Nam.   

Abstract

Ensemble averaging after pre-editing of surface EMG potentials has enabled construction of underlying controller signals from stereotyped head movements. Carefully controlled, intended time-optimal movements by trained, actively participating human subjects have been found to yield repeatable, multi-pulse controller signals. Also, adaptive changes in these horizontal head movements in response to added viscous loads showed further causal relationships between movement dynamics and EMG signals from left and right splenius muscles. These experimental results are a base from which modeling studies can be performed to explicate the neurological control strategies used in the performance of this class of movements.

Entities:  

Year:  1984        PMID: 15151852     DOI: 10.1080/00222895.1984.10735320

Source DB:  PubMed          Journal:  J Mot Behav        ISSN: 0022-2895            Impact factor:   1.328


  5 in total

1.  The control of oscillatory movements of the forearm.

Authors:  G K Wallace
Journal:  Biol Cybern       Date:  1989       Impact factor: 2.086

2.  Late agonist activation burst (PC) required for optimal head movement: a simulation study.

Authors:  B Hannaford; L Stark
Journal:  Biol Cybern       Date:  1987       Impact factor: 2.086

3.  Muscle models: what is gained and what is lost by varying model complexity.

Authors:  J M Winters; L Stark
Journal:  Biol Cybern       Date:  1987       Impact factor: 2.086

4.  Effects of different types of mechanical load on the duration of the initial agonist pulse.

Authors:  R W Simmons; C Richardson
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

5.  Behaviour space of a stretch reflex model and its implications for the neural control of voluntary movement.

Authors:  C F Ramos; S S Hacisalihzade; L W Stark
Journal:  Med Biol Eng Comput       Date:  1990-01       Impact factor: 2.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.